Zilganersen Expanded Access Program for Individuals With Alexander Disease

NCT07487389 · clinicaltrials.gov ↗

AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Alexander Disease

Interventions

DRUG: zilganersen

Sponsor

Ionis Pharmaceuticals, Inc.